Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Using Bayes' theorem to answer a practical heart valve question.

Gary L Grunkemeier1

  • 1Providence Health System, Portland, Oregon, USA.

The Journal of Heart Valve Disease
|December 14, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

In Memoriam: Albert Starr, MD, 1926-2024.

The Annals of thoracic surgery·2025
Same author

Individualized Prediction for Risk of Recurrence in Stage I/II Melanoma Patients With Negative Sentinel Lymph Node.

Cancer medicine·2024
Same author

Propensity scores used as overlap weights provide exact covariate balance.

European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery·2024
Same author

A simplified pneumonia severity index (PSI) for clinical outcome prediction in COVID-19.

PloS one·2024
Same author

Characterization of Lymph Node Tumor Burden in Node-Positive Prostate Cancer Patients after Robotic-Assisted Radical Prostatectomy with Extended Pelvic Lymph Node Dissection.

Cancers·2023
Same author

Impact of Mediating and Confounding Variables on the Volume-Outcome Association in the Treatment of Pancreatic Cancer.

Annals of surgical oncology·2022
Same journal

Impact of Patient-Specific Material Properties on Aneurysm Wall Stress: Finite Element Study.

The Journal of heart valve disease·2021
Same journal

Range of Pulmonary Autograft Responses to Systemic Pressure Immediately After Ross Procedure.

The Journal of heart valve disease·2021
Same journal

Evolution of Bilateral Mammary Arterial Grafting Program in Veterans Affairs Medical Center.

The Journal of heart valve disease·2021
Same journal

Double Valve Failure Due to Perceval Sutureless Aortic Valve Migration.

The Journal of heart valve disease·2018
Same journal

Use of AngioVac for Removal of Tricuspid Valve Vegetation.

The Journal of heart valve disease·2018
Same journal

Management of Late Paravalvular Leak after Transcatheter Valve Placement in Calcified Mitral Annulus.

The Journal of heart valve disease·2018
See all related articles

Patients with mechanical heart valves who remain free of thromboembolism (TE) for 15 years have a significantly reduced risk. This reduced risk is approximately one-third of the initial risk, though individual patient risk varies.

Area of Science:

  • Biostatistics
  • Cardiovascular Medicine
  • Medical Device Research

Background:

  • Thromboembolism (TE) risk in mechanical heart valve patients after 15 years without events is not well-defined.
  • Patient populations exhibit heterogeneity in embolic risk, suggesting a subset with lower inherent risk.
  • Quantifying this reduced risk in long-term survivors is crucial for risk stratification.

Purpose of the Study:

  • To quantify the reduced thromboembolism (TE) risk in mechanical heart valve patients 15 years post-implantation without prior TE or thrombosis.
  • To estimate the distribution of TE risk within a population of long-term survivors.
  • To assess the utility of Bayesian methods for updating risk estimates based on event-free survival.

Main Methods:

  • Modeling TE-free survival curves using parametric functions to estimate the mixing distribution of risks.

Related Experiment Videos

  • Utilizing Bayes' theorem to update risk distributions for patients with observed event-free periods (e.g., 15 years).
  • Analysis of Starr-Edwards valve data to derive risk distributions over time.

    • Main Results:

    • The estimated mean (median) annual TE risk for aortic valve patients decreased from 4.5% (1.8%) at implant to 1.7% (0.7%) at 15 years.
    • For mitral valve patients, the mean (median) annual TE risk fell from 7.0% (3.4%) at implant to 2.4% (1.2%) at 15 years.
    • After 15 TE-free years, the average risk was approximately 35-40% of the initial implant risk for both valve positions.

    Conclusions:

    • The average TE risk for patients with 15 TE-free years is about one-third of the initial risk at implantation.
    • Significant heterogeneity in risk persists, with some patients maintaining higher risk profiles.
    • Bayesian updating of risk distributions is valuable, while linearized rates offer limited insight into heterogeneous populations.